Delire, Bénédicte <br/><br/>
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications.  [electronic resource] 

 -  European journal of clinical investigation  Jun 2015 
 - 609-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1365-2362 
<br/><br/><label>Standard No.: </label>10.1111/eci.12441  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Apoptosis Regulatory Proteins<br/>Carcinogenesis--metabolism<br/>Carcinoma, Hepatocellular--drug therapy<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--physiology<br/>Liver Neoplasms--drug therapy<br/>MAP Kinase Signaling System--physiology<br/>Membrane Proteins--physiology<br/>Mice<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Monomeric GTP-Binding Proteins--physiology<br/>Mutation--genetics<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Rats<br/>Sorafenib<br/>Tumor Suppressor Proteins--physiology<br/>raf Kinases--metabolism<br/>ras GTPase-Activating Proteins--antagonists & inhibitors<br/>ras Proteins--antagonists & inhibitors